Tumor necrosis factor-(TNF-) is an important cytokine associated with tumor regression and increased survival time for cancer patients. Research evidence relates immune factors (e.g., natural killer (NK) cell counts, NK cell lysis, lymphocyte proWle, and lymphocyte proliferation) to the frequency and quality of social relations among cancer patients. We hypothesized that disruptions in social relations would be associated with lower TNF-responses, and conversely, that reports of positive changes in social relations correlate with stronger responses. A prospective design measured changes in social activity and relationship satisfaction with a partner in 44 breast cancer patients at the time of cancer diagnosis, and initial surgery and 12 months later. Results indicated that patients reporting increased social activities or satisfaction exhibited stronger stimulated TNF-responses. This is the Wrst study to link changes in patient social relations with a cancer-relevant immune variable. 
Introduction
In the psychoneuroimmunology literature, social variables have been reliably, and positively, associated with immunity (Uchino et al., 1996) . In healthy samples, immune functioning has been linked to the number of social relationships and interactions, and perceptions of and satisfaction with support (Gerits and De Brabander, 1999) . Similar data come from two studies of cancer patients. Levy et al. (1990) found natural killer (NK) cell activity to be positively associated with quality of emotional support from a spouse, and Lekander et al. (1996) related white blood cell count to the adequacy of social attachments assessed following chemotherapy.
Like NK cells, cytokines are important immune factors. These soluble mediator molecules induce, enhance, or eVect immune responses (DranoV, 2004) . Tumor necrosis factor-(TNF-) in particular is a potent proinXammatory cytokine associated with tumor regression and increased survival time for cancer patients (Nakamoto et al., 2000) . Its tumorcidal mechanisms range from the activating host cellular immunity to directly killing tumor cells. At the tumor site, TNF-induces cell apoptosis within the angiogenic vasculature, leading to hemorrhagic necrosis (reviewed in Anderson et al., 2004) . By inducing vascular permeability of the tumor, TNFfacilitates uptake of chemotherapeutic drugs such as doxorubicin (reviewed in Eggermont et al., 2003) .
TNF-has well-known cytotoxic eVects on human breast cancer cells (Weitsman et al., 2003 (Weitsman et al., , 2004 . Unfortunately, the blood cells of breast cancer patients have impaired ability to produce TNF- (Zielinski et al., 1990 (Zielinski et al., , 2003 . The potential relevance of TNF-production to
